Endocrine Abstracts

Aim of the study: To examine the white blood cell count and the platelet count in type 2 diabetic patients vs. age-matched healthy controls, as well as to investigate if the abovementioned counts are associated with parameters of diabetes.Methods: This study included 337 subjects, divided into two groups. Group A comprised 190 type 2 diabetic patients (98 men, mean age 66.5±9.6 years, mean diabetes duration 11.7±8.6 years). Group B comprised 14...

Background: One of the most important complications of the One Anastomosis Gastric Bypass (OAGB) is enterobilioacid reflux (EBAR). We report the concept of the Long Pouch Roux-en Y Gastric Bypass (LPRYGB) meaning a Roux-en-Y with a long pouch and a 100 cm alimentary limb to avoid EBAR, with a long biliopancreatic limb to increase metabolic effects.Methods: A total of 300 LPRYGB cases in a four-year period, with a 90% follow up rate, were analyzed. Anthro...

Hyperinsulinaemic-hypoglycaemia has been described following Roux-en-Y gastric bypass for obesity and is thought to be due to hyperfunction of pancreatic β cells. It has been questioned whether the β cell hyperfunction may have preceded the bariatric surgery and contributed to the obesity. We report a case of hyperinsulinaemic-hypoglycaemia in a non-diabetic, lean patient (BMI 26 kg/m2) who underwent distal gastrectomy and Roux-en-Y bypass for a benign gas...

Importance: Few studies have compared mid-term results of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy and none have focussed on lipid profile.Objectives: The main objective of this study was to compare laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy with respect to 5-year remission rate of the different lipid disturbances. Secondary outcomes included relapse, late remission and incidence rates...

Background: Obesity is associated with increased insulin resistance, type 2 diabetes and increased cardiovascular risk leading to atherosclerosis. Bariatric surgery has been shown to improve some of these factors in obese patients with glucose intolerance. A form of bariatric surgery is the Roux-en-Y procedure which can result in greater weight loss and restriction with less malabsorption than other procedures (such as the bilious-pancreatic diversion); but the effect of some ...

Background: Obesity is a major modifiable risk factor for cardiovascular disease. Bariatric surgery is considered to be the most effective treatment option for weight reduction in obese patients with and without type 2 diabetes.Aims: To evaluate changes in lipoproteins, insulin resistance, mediators of systemic and vascular inflammation and endothelial dysfunction following Roux-en-Y bariatric surgery in obese patients with a...

Background: Obesity is a major modifiable risk factor for cardiovascular disease. Bariatric surgery is considered to be the most effective treatment option for weight reduction in obese patients with and without type 2 diabetes.Aims: To evaluate changes in lipoproteins, insulin resistance, mediators of systemic and vascular inflammation and endothelial dysfunction following Roux-en-Y bariatric surgery in obese patients with a...

A 45-year-old female presented with recurrent episodes of neuroglycopaenic symptoms 6 years after Roux-en-Y gastric bypass surgery. Her symptoms occurred during both the fasting and postprandial state. She had a history of Rheumatoid Arthritis. Her symptoms did not response to a complex carbohydrate diet or Acarbose use.Whipple’s triad was demonstrated during a 72 h fast; symptomatic hypoglycaemia (1.8 mmol/l) occurred which resolved with glucose ad...

We present the case of a 50-year-old male who developed severe hypoglycaemia after Roux-en-Y gastric bypass (RYGB), illustrating the role of selective arterial calcium stimulation test (SACST) in the diagnosis and management of hypoglycemia. Our patient presented with recurrent hypoglycaemia one to two hours after meals, which started 15 years post RYGB performed for morbid obesity with hypertension, impaired glucose tolerance, NAFLD and ischemic heart disease. The hypoglycaem...

Introduction: Primary hyperparathyroidism is a condition in which one or more parathyroid glands have a pathological secretion of parathyroid hormone due to their abnormal function. Secondary hyperparathyroidism has normal parathyroid glands, but an abnormal secretion of PTH because of an underlying condition that influence their activity. It is important to differentiate between primary and secondary hyperparathyroidism because of the different treatment.<p class="abstext...